Abstract
Multiplex assays that provide simultaneous measurement of multiple analytes in biological samples have now developed into widely used technologies in the study of diseases, drug discovery, and other medical areas. These approaches span multiple assay systems and can provide readouts of specific assay components with similar accuracy as the respective single assay measurements. Multiplexing allows the consumption of lower sample volumes, lower costs, and higher throughput compared with carrying out single assays. A number of recent studies have demonstrated the impact of multiplex assays in the study of the SARS-CoV-2 virus, the infectious agent responsible for the current COVID-19 pandemic. In this respect, machine learning techniques have proven to be highly valuable in capturing complex disease phenotypes and converting these insights into models which can be applied in real-world settings. This chapter gives an overview of opportunities and challenges of multiplexed biomarker analysis, with a focus on the use of machine learning aimed at identification of biological signatures for increasing our understanding of COVID-19 disease, and for improved diagnostics and prediction of disease outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Guest PC (2017) Multiplex biomarker techniques: methods and applications, Methods in molecular biology, 1546. Humana Press/Springer, New York. ISBN-13: 978-1493967292
Xu T, Fang Y, Rong A et al (2015) Flexible combination of multiple diagnostic biomarkers to improve diagnostic accuracy. BMC Med Res Methodol 15:94. https://doi.org/10.1186/s12874-015-0085-z
Ransohoff DF (2005) Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 5(2):142–149
Fontela PS, Pai NP, Schiller I et al (2009) Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards. PLoS One 4(11):e7753. https://doi.org/10.1371/journal.pone.0007753
Köhler K, Seitz H (2012) Validation processes of protein biomarkers in serum–a cross platform comparison. Sensors (Basel) 12(9):12710–12728
Chen J, Guest PC, Schwarz E (2017) The utility of multiplex assays for identification of proteomic signatures in psychiatry. Adv Exp Med Biol 974:131–138
Raschka S, Mirjalili V (2019) Python machine learning: machine learning and deep learning with python, scikit-learn, and TensorFlow 2, 3rd edn. Packt Publishing, Birmingham. ISBN-13: 978-1789955750
Ghods A, Cook DJ (2021) A survey of deep network techniques all classifiers can adopt. Data Min Knowl Discov 35(1):46–87
Yu CS, Chang SS, Chang TH et al (2021) A COVID-19 pandemic artificial intelligence-based system with deep learning forecasting and automatic statistical data acquisition: development and implementation study. J Med Internet Res 23(5):e27806. https://doi.org/10.2196/27806
Cortes C, Vapnik V (1995) Support-vector networks. Mach Learn 20:273–297
Ho TK (1995) Random Decision Forest. In: Proceedings of the 3rd international conference on document analysis and recognition, Montreal, 14–16 August 1995, pp 278–282
Chen J, Schwarz E (2017) Opportunities and challenges of multiplex assays: a machine learning perspective. Methods Mol Biol 1546:115–122
Cabitza F, Campagner A, Soares F et al (2021) The importance of being external. Methodological insights for the external validation of machine learning models in medicine. Comput Methods Prog Biomed 208(106288). https://doi.org/10.1016/j.cmpb.2021.106288
Worldometer. COVID-19 coronavirus pandemic. https://www.worldometers.info/coronavirus/#countries. Accessed 24 Nov 2021
World Health Organization. Tracking SARS-CoV-2 variants. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. Accessed 8 Oct 2021
How AI and machine learning are helping to fight COVID-19. https://www.weforum.org/agenda/2020/05/how-ai-and-machine-learning-are-helping-to-fight-covid-19/. Accessed 9 Oct 2021
Papoutsoglou G, Karaglani M, Lagani V et al (2021) Automated machine learning optimizes and accelerates predictive modeling from COVID-19 high throughput datasets. Sci Rep 11(1):15107. https://doi.org/10.1038/s41598-021-94501-0
Lazari LC, Ghilardi FR, Rosa-Fernandes L et al (2021) Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19. Life Sci Alliance 4(8):e202000946. https://doi.org/10.26508/lsa.202000946
Krysko O, Kondakova E, Vershinina O et al (2021) Artificial intelligence predicts severity of COVID-19 based on correlation of exaggerated monocyte activation, excessive organ damage and Hyperinflammatory syndrome: a prospective clinical study. Front Immunol 12:715072. https://doi.org/10.3389/fimmu.2021.715072
Karami H, Derakhshani A, Ghasemigol M et al (2021) Weighted gene co-expression network analysis combined with machine learning validation to identify key modules and hub genes associated with SARS-CoV-2 infection. J Clin Med 10(16):3567. https://doi.org/10.3390/jcm10163567
Sardar R, Sharma A, Gupta D (2021) Machine learning assisted prediction of prognostic biomarkers associated with COVID-19, using clinical and proteomics data. Front Genet 12:636441. https://doi.org/10.3389/fgene.2021.636441
Sindelar M, Stancliffe E, Schwaiger-Haber M et al (2021) Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med 2(8):100369. https://doi.org/10.1016/j.xcrm.2021.100369
Luo J, Zhou L, Feng Y et al (2021) The selection of indicators from initial blood routine test results to improve the accuracy of early prediction of COVID-19 severity. PLoS One 16(6):e0253329. https://doi.org/10.1371/journal.pone.0253329
Lin JK, Chien TW, Wang LY et al (2021) An artificial neural network model to predict the mortality of COVID-19 patients using routine blood samples at the time of hospital admission: development and validation study. Medicine (Baltimore) 100(28):e26532. https://doi.org/10.1097/MD.0000000000026532
Ye J, Hua M, Zhu F (2021) Machine learning algorithms are superior to conventional regression models in predicting risk stratification of COVID-19 patients. Risk Manag Healthc Policy 14:3159–3166
Karthikeyan A, Garg A, Vinod PK et al (2021) Machine learning based clinical decision support system for early COVID-19 mortality prediction. Front Public Health 9:626697. https://doi.org/10.3389/fpubh.2021.626697
Kukar M, Gunčar G, Vovko T et al (2021) COVID-19 diagnosis by routine blood tests using machine learning. Sci Rep 11(1):10738. https://doi.org/10.1038/s41598-021-90265-9
Rahman T, Al-Ishaq FA, Al-Mohannadi FS et al (2021) Mortality prediction utilizing blood biomarkers to predict the severity of COVID-19 using machine learning technique. Diagnostics (Basel) 11(9):1582. https://doi.org/10.3390/diagnostics11091582
Blagojević A, Šušteršič T, Lorencin I et al (2021) Artificial intelligence approach towards assessment of condition of COVID-19 patients – identification of predictive biomarkers associated with severity of clinical condition and disease progression. Comput Biol Med 3:104869. https://doi.org/10.1016/j.compbiomed.2021.104869. Online ahead of print
Lee EE, Hwang W, Song KH et al (2021) Predication of oxygen requirement in COVID-19 patients using dynamic change of inflammatory markers: CRP, hypertension, age, neutrophil and lymphocyte (CHANeL). Sci Rep 11(1):13026. https://doi.org/10.1038/s41598-021-92418-2
Pulgar-Sánchez M, Chamorro K, Fors M et al (2021) Biomarkers of severe COVID-19 pneumonia on admission using data-mining powered by common laboratory blood tests-datasets. Comput Biol Med 136:104738 cccccv. https://doi.org/10.1016/j.compbiomed.2021.104738
Lombardi C, Roca E, Bigni B et al (2021) Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients. Curr Res Immunol 2:155–162. https://doi.org/10.1016/j.crimmu.2021.09.001
Song J, Wang H, Liu Y et al (2020) End-to-end automatic differentiation of the coronavirus disease 2019 (COVID-19 ) from viral pneumonia based on chest CT. Eur J Nucl Med Mol Imaging 47(11):2516–2524
Sakagianni A, Feretzakis G, Kalles D et al (2020) Setting up an easy-to-use machine learning pipeline for medical decision support: a case study for COVID-19 diagnosis based on deep learning with CT scans. Stud Health Technol Inform 272:13–16
Li Z, Zhong Z, Li Y et al (2020) From community-acquired pneumonia to COVID-19: a deep learning-based method for quantitative analysis of COVID-19 on thick-section CT scans. Eur Radiol 30(12):6828–6837
Han Z, Wei B, Hong Y et al (2020) Accurate screening of COVID-19 using attention-based deep 3D multiple instance learning. IEEE Trans Med Imaging 39(8):2584–2594
Ouyang X, Huo J, Xia L et al (2020) Dual-sampling attention network for diagnosis of COVID-19 from community acquired pneumonia. IEEE Trans Med Imaging 39(8):2595–2605
Sun L, Mo Z, Yan F et al (2020) Adaptive feature selection guided deep Forest for COVID-19 classification with chest CT. IEEE J Biomed Health Inform 24(10):2798–2805
Jin C, Chen W, Cao Y et al (2020) Development and evaluation of an artificial intelligence system for COVID-19 diagnosis. Nat Commun 11(1):5088. https://doi.org/10.1038/s41467-020-18685-1
Cai W, Liu T, Xue X et al (2020) CT quantification and machine-learning models for assessment of disease severity and prognosis of COVID-19 patients. Acad Radiol 27(12):1665–1678
Wang X, Deng X, Fu Q et al (2020) A weakly-supervised framework for COVID-19 classification and lesion localization from chest CT. IEEE Trans Med Imaging 39(8):2615–2625
Wu X, Hui H, Niu M et al (2020) Deep learning-based multi-view fusion model for screening 2019 novel coronavirus pneumonia: a multicentre study. Eur J Radiol 128:109041. https://doi.org/10.1016/j.ejrad.2020.109041
Yang Y, Lure FYM, Miao H et al (2021) Using artificial intelligence to assist radiologists in distinguishing COVID-19 from other pulmonary infections. J Xray Sci Technol 29(1):1–17
Xie Q, Lu Y, Xie X et al (2021) The usage of deep neural network improves distinguishing COVID-19 from other suspected viral pneumonia by clinicians on chest CT: a real-world study. Eur Radiol 31(6):3864–3873
Liu H, Ren H, Wu Z et al (2021) CT radiomics facilitates more accurate diagnosis of COVID-19 pneumonia: compared with CO-RADS. J Transl Med 19(1):29. https://doi.org/10.1186/s12967-020-02692-3
Wang L, Kelly B, Lee EH et al (2021) Multi-classifier-based identification of COVID-19 from chest computed tomography using generalizable and interpretable radiomics features. Eur J Radiol 136:109552. https://doi.org/10.1016/j.ejrad.2021.109552
Chen H, Guo S, Hao Y et al (2021) Auxiliary diagnosis for COVID-19 with deep transfer learning. J Digit Imaging 34(2):231–241
Yao JC, Wang T, Hou GH et al (2021) AI detection of mild COVID-19 pneumonia from chest CT scans. Eur Radiol 31(9):7192–7201
Rezaeijo SM, Abedi-Firouzjah R, Ghorvei M et al (2021) Screening of COVID-19 based on the extracted radiomics features from chest CT images. J Xray Sci Technol 29(2):229–243
Yang Z, Zhao L, Wu S et al (2021) Lung lesion localization of COVID-19 from chest CT image: a novel weakly supervised learning method. IEEE J Biomed Health Inform 25(6):1864–1872
Xiong F, Wang Y, You T et al (2021) The clinical classification of patients with COVID-19 pneumonia was predicted by Radiomics using chest CT. Medicine (Baltimore) 100(12):e25307. https://doi.org/10.1097/MD.0000000000025307
Ibrahim DM, Elshennawy NM, Sarhan AM (2021) Deep-chest: multi-classification deep learning model for diagnosing COVID-19, pneumonia, and lung cancer chest diseases. Comput Biol Med 132:104348. https://doi.org/10.1016/j.compbiomed.2021.104348
Zhang B, Ni-Jia-Ti MY, Yan R et al (2021) CT-based radiomics for predicting the rapid progression of coronavirus disease 2019 (COVID-19 ) pneumonia lesions. Br J Radiol 94(1122):20201007. https://doi.org/10.1259/bjr.20201007
Goncharov M, Pisov M, Shevtsov A et al (2021) CT-based COVID-19 triage: deep multitask learning improves joint identification and severity quantification. Med Image Anal 71:102054. https://doi.org/10.1016/j.media.2021.102054
Yousefzadeh M, Esfahanian P, Movahed SMS et al (2021) Ai-corona: radiologist-assistant deep learning framework for COVID-19 diagnosis in chest CT scans. PLoS One 16(5):e0250952. https://doi.org/10.1371/journal.pone.0250952
Bartolucci M, Benelli M, Betti M et al (2021) The incremental value of computed tomography of COVID-19 pneumonia in predicting ICU admission. Sci Rep 11(1):15619. https://doi.org/10.1038/s41598-021-95114-3
Chen HJ, Mao L, Chen Y et al (2021) Machine learning-based CT radiomics model distinguishes COVID-19 from non-COVID-19 pneumonia. BMC Infect Dis 21(1):931. https://doi.org/10.1186/s12879-021-06614-6
Yang N, Liu F, Li C et al (2021) Diagnostic classification of coronavirus disease 2019 (COVID-19 ) and other pneumonias using radiomics features in CT chest images. Sci Rep 11(1):17885. https://doi.org/10.1038/s41598-021-97497-9
Gong K, Wu D, Arru CD et al (2021) A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records. Eur J Radiol 139:109583. https://doi.org/10.1016/j.ejrad.2021.109583
Jafari R, Ashtari S, Pourhoseingholi MA et al (2021) Identification, monitoring, and prediction of disease severity in patients with COVID-19 pneumonia based on chest computed tomography scans: a retrospective study. Adv Exp Med Biol 1321:265–275
Pourhoseingholi A, Vahedi M, Chaibakhsh S et al (2021) Deep learning analysis in prediction of COVID-19 infection status using chest CT scan features. Adv Exp Med Biol 1327:139–147
Lassau N, Ammari S, Chouzenoux E et al (2021) Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients. Nat Commun 12(1):634. https://doi.org/10.1038/s41467-020-20657-4
Xia Y, Chen W, Ren H et al (2021) A rapid screening classifier for diagnosing COVID-19. Int J Biol Sci 17(2):539–548
Weikert T, Rapaka S, Grbic S et al (2021) Prediction of patient management in COVID-19 using deep learning-based fully automated extraction of cardiothoracic CT metrics and laboratory findings. Korean J Radiol 22(6):994–1004
Shiri I, Sorouri M, Geramifar P et al (2021) Machine learning-based prognostic modeling using clinical data and quantitative radiomic features from chest CT images in COVID-19 patients. Comput Biol Med 132:104304. https://doi.org/10.1016/j.compbiomed.2021.104304
Purkayastha S, Xiao Y, Jiao Z et al (2021) Machine learning-based prediction of COVID-19 severity and progression to critical illness using CT imaging and clinical data. Korean J Radiol 22(7):1213–1224
Du R, Tsougenis ED, Ho JWK et al (2021) Machine learning application for the prediction of SARS-CoV-2 infection using blood tests and chest radiograph. Sci Rep 11(1):14250. https://doi.org/10.1038/s41598-021-93719-2
Poduri R, Joshi G, Jagadeesh G (2020) Drugs targeting various stages of the SARS-CoV-2 life cycle: exploring promising drugs for the treatment of Covid-19. Cell Signal 74:109721. https://doi.org/10.1016/j.cellsig.2020.109721
Jin W, Stokes JM, Eastman RT et al (2021) Deep learning identifies synergistic drug combinations for treating COVID-19. Proc Natl Acad Sci U S A 118(39):e2105070118. https://doi.org/10.1073/pnas.2105070118
Caires Silveira E (2021) Screening anti-inflammatory, anticoagulant, and respiratory agents for SARS-CoV-2 3CL(pro) inhibition from chemical fingerprints through a deep learning approach. Rev Investig Clin. https://doi.org/10.24875/RIC.21000282. Online ahead of print
Liang H, Zhao L, Gong X et al (2021) Virtual screening FDA approved drugs against multiple targets of SARS-CoV-2. Clin Transl Sci 14(3):1123–1132
Yousefi H, Mashouri L, Okpechi SC et al (2021) Repurposing existing drugs for the treatment of COVID-19 /SARS-CoV-2 infection: a review describing drug mechanisms of action. Biochem Pharmacol 183:114296. https://doi.org/10.1016/j.bcp.2020.114296
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Guest, P.C., Popovic, D., Steiner, J. (2022). Challenges of Multiplex Assays for COVID-19 Research: A Machine Learning Perspective. In: Guest, P.C. (eds) Multiplex Biomarker Techniques. Methods in Molecular Biology, vol 2511. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2395-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2395-4_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2394-7
Online ISBN: 978-1-0716-2395-4
eBook Packages: Springer Protocols